Greater Suppression of Nevirapine Resistance With 21- vs 7-Day Antiretroviral Regimens After Intrapartum Single-Dose Nevirapine for Prevention of Mother-to-Child Transmission of HIV | Zendy

D. K. McMahon | Zendy; Lei Zheng | Zendy; Jane Hitti | Zendy; Edwin SY Chan | Zendy; Elias K. Halvas | Zendy; Feiyu Hong | Zendy; Joseph Kabanda | Zendy; Frank Taulo | Zendy; N. Kumarasamy | Zendy; Julie Bonhomme | Zendy; Carole L. Wallis | Zendy; Karin L. Klingman | Zendy; Michael D. Hughes | Zendy; J. W. Mellors | Zendy

Open Access

Greater Suppression of Nevirapine Resistance With 21- vs 7-Day Antiretroviral Regimens After Intrapartum Single-Dose Nevirapine for Prevention of Mother-to-Child Transmission of HIV

Author(s) -

D. K. McMahon,

Lei Zheng,

Jane Hitti,

Edwin SY Chan,

Elias K. Halvas,

Feiyu Hong,

Joseph Kabanda,

Frank Taulo,

N. Kumarasamy,

Julie Bonhomme,

Carole L. Wallis,

Karin L. Klingman,

Michael D. Hughes,

J. W. Mellors

Publication year - 2013

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cis1219

Subject(s) - nevirapine , medicine , resistance mutation , emtricitabine , population , lamivudine , clinical endpoint , virology , ritonavir , zidovudine , randomized controlled trial , viral load , human immunodeficiency virus (hiv) , reverse transcriptase , virus , viral disease , biology , antiretroviral therapy , hepatitis b virus , genetics , polymerase chain reaction , environmental health , gene

Nevirapine (NVP) resistance emerges in up to 70% of women exposed to single-dose (sd) NVP for prevention of mother-to-child transmission of human immunodeficiency virus (HIV).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research